探索多发性硬化症疾病修饰疗法和BTK抑制剂与的相关性
Afsaneh Shirani1, Nil Saez-Calveras2,3, Jack P Antel4
1Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Therapeutic advances in neurological disorders
|October 7, 2024
概括
一些药物,包括布鲁顿氨酸激酶抑制剂和多发性硬化症疗法,显示与的反向关联. 这些发现表明治疗的潜在重用,并强调白细胞在发作中的作用.
科学领域:
- 神经免疫学 神经免疫学
- 药物监督 药物监督 药物监督
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 炎症与的发病因子有关.
- 与普通人群相比,患有多发性硬化症 (MS) 的患者的发作发病率高出2-3倍.
研究的目的:
- 调查MS疾病修饰疗法 (DMT) 和布鲁顿氨酸激酶 (BTK) 抑制剂与发作的关联.
- 使用美国食品和药物管理局不良事件报告系统 (FAERS) 数据库进行全面分析.
主要方法:
- 从2003年第四季度到2023年第三季度,FAERS数据库的不成比例分析.
- 包括MS DMTs和BTK抑制剂易布鲁替尼.
- 通过95%的置信区间来定义反向关联报告几率比率 (ROR) 的上限<1.1.
主要成果:
- 在ibrutinib,ocrelizumab,ofatumumab,rituximab和teriflunomide与之间观察到一个反向的关联.
- 易布鲁替尼表现出最强的反向关联 (ROR:0.338;95% CI:0.218-0.524).
结论:
- 这项研究表明,这些药物可能用于治疗.
- 这些发现支持白细胞子集在发作延续中的作用.
相关概念视频
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Glutamate Antagonists
292
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
Electroconvulsive Therapy
28
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
28


